[go: up one dir, main page]

DK1625148T3 - Peptidkompleks - Google Patents

Peptidkompleks

Info

Publication number
DK1625148T3
DK1625148T3 DK04733537.7T DK04733537T DK1625148T3 DK 1625148 T3 DK1625148 T3 DK 1625148T3 DK 04733537 T DK04733537 T DK 04733537T DK 1625148 T3 DK1625148 T3 DK 1625148T3
Authority
DK
Denmark
Prior art keywords
peptide complex
peptide
complex
Prior art date
Application number
DK04733537.7T
Other languages
English (en)
Inventor
Isabelle Galy-Fauroux
Frederic Henot
Thierry Legon
Jean Duchateau
Original Assignee
Biotech Tools Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP03011498A external-priority patent/EP1479689A1/en
Application filed by Biotech Tools Sa filed Critical Biotech Tools Sa
Priority claimed from PCT/EP2004/005316 external-priority patent/WO2004104026A1/en
Application granted granted Critical
Publication of DK1625148T3 publication Critical patent/DK1625148T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43531—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Insects & Arthropods (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK04733537.7T 2003-05-21 2004-05-18 Peptidkompleks DK1625148T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US47213103P 2003-05-21 2003-05-21
EP03011498A EP1479689A1 (en) 2003-05-21 2003-05-21 Peptide complex
EP04006900 2004-03-23
PCT/EP2004/005316 WO2004104026A1 (en) 2003-05-21 2004-05-18 Peptide complex

Publications (1)

Publication Number Publication Date
DK1625148T3 true DK1625148T3 (da) 2013-01-14

Family

ID=37464331

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04733537.7T DK1625148T3 (da) 2003-05-21 2004-05-18 Peptidkompleks

Country Status (3)

Country Link
US (1) US8436136B2 (da)
DK (1) DK1625148T3 (da)
ES (1) ES2396231T3 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2728363C (en) 2008-06-26 2019-02-19 Orphazyme Aps Use of hsp70 as a regulator of enzymatic activity
PL2646044T3 (pl) 2010-11-30 2020-03-31 Orphazyme A/S Sposoby zwiększenia aktywności wewnątrzkomórkowej Hsp70
JP6678676B2 (ja) 2014-09-15 2020-04-08 オーファザイム エー／エス アリモクロモル製剤
US10898476B2 (en) 2016-04-13 2021-01-26 Orphazyme A/S Heat shock proteins and cholesterol homeostasis
BR112018070653A2 (pt) 2016-04-29 2019-02-05 Orphazyme As ingrediente farmacêutico ativo, e, composição
AU2021380947C1 (en) 2020-11-19 2025-02-20 Zevra Denmark A/S Processes for preparing arimoclomol citrate and intermediates thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3907765A (en) 1973-06-29 1975-09-23 Hoffmann La Roche Process for preparing octapeptide intermediate for human insulin and intermediates
DE2460753A1 (de) 1974-12-21 1976-06-24 Hoechst Ag Verfahren zur herstellung von humaninsulin
SU1147010A1 (ru) * 1983-07-04 1985-12-15 Институт Экспериментальной Эндокринологии И Химии Гормонов Амн Ссср Способ получени октапептида
WO1990014835A1 (en) 1989-05-31 1990-12-13 Scripps Clinic And Research Foundation Method to treat rheumatoid arthritis
US5773570A (en) 1994-05-20 1998-06-30 The Regents Of The University Of California Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis
IL123219A0 (en) 1995-08-18 1998-09-24 Sloan Kettering Inst Cancer Method for treatment of cancer and infectious diseases and compositions useful in same
US5869270A (en) 1996-01-31 1999-02-09 Sunol Molecular Corporation Single chain MHC complexes and uses thereof
US6519601B1 (en) * 1996-05-22 2003-02-11 Universitaire Ziekenhuizen Leuven Relational database compiled/stored on a memory structure providing improved access through use of redundant representation of data
BE1011033A6 (fr) 1997-03-05 1999-04-06 Univ Bruxelles Composition pharmaceutique et/ou alimentaire pour le traitement de pathologies liees a un rejet de greffe, une reaction allergique ou auto-immune ou du cancer.
US7030098B2 (en) 1999-03-12 2006-04-18 The Board Of Trustees Of The Leland Stanford Junior University DNA vaccination for treatment of autoimmune disease
FR2806727A1 (fr) 2000-03-23 2001-09-28 Pf Medicament Molecule d'interet pharmaceutique comprotant en son extremite n-terminale un acide glutamique ou une glutamine sous forme de sel d'addition d'acide fort physiologiquement acceptable
AU2001257087A1 (en) 2000-04-17 2001-10-30 Mojave Therapeutics Inc. Heat shock protein-based antiviral vaccines
CN1107681C (zh) * 2000-08-11 2003-05-07 中国科学院微生物研究所 乙肝病毒抗原多肽与热休克蛋白的复合物及其应用
US20030049797A1 (en) * 2001-04-16 2003-03-13 Yoshikazu Yuki Hybrid proteins for autoimmune disease
US20030096748A1 (en) 2001-06-04 2003-05-22 The Regents Of The University Of Michigan Methods and compositions for the treatment of diseases associated with signal transduction aberrations
DE10228103A1 (de) 2002-06-24 2004-01-15 Bayer Cropscience Ag Fungizide Wirkstoffkombinationen
EP2316844A3 (en) 2003-05-21 2011-07-20 Biotech Tools S.A. Peptide complex

Also Published As

Publication number Publication date
US8436136B2 (en) 2013-05-07
ES2396231T3 (es) 2013-02-20
US20060270833A1 (en) 2006-11-30

Similar Documents

Publication Publication Date Title
NO2014013I2 (no) Linaclotide
DE502004001683D1 (de) Kabelführung
DK1653844T3 (da) Prionspecifikke peptidreagenser
AT502792A5 (de) Düsenanpressvorrichtung
DE112004000620D2 (de) Struktoguss
DE10355350A8 (de) Elektromodul
DE502004000672D1 (de) Pigmentpreparationen
DE502004001524D1 (de) Hydrolager
ATA662003A (de) Trink-mundstück
DE502004001629D1 (de) Bremsenprüfstand
DE502004002978D1 (de) N-biarylamide
DK1664096T3 (da) Antimikrobielle peptider
DE502004003122D1 (de) Hydrolager
DK1625148T3 (da) Peptidkompleks
EP1591451A4 (en) peptide conjugate
DE502004000518D1 (de) Mitgängergabelhubwagen
DE112004002227D2 (de) Nietverarbeitungsgerät
DE502004006563D1 (de) Brieftaubenkonstatiersystem
DE502004005162D1 (de) Leistungsregelvorricthung
DE10394329D2 (de) Mäanderstent
DE10329218B4 (de) Hotflue
DE502004007251D1 (de) En 2-arylpropenalen
DE502004002619D1 (de) Flaschenverschluss
DE502004004175D1 (de) Verbrennungskraftmaschime
DE502004002771D1 (de) Umlenkhebel